Core Scientific, Inc.
CORZ
$16.42
-$0.55-3.24%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -11.89% | -42.37% | -40.66% | -28.48% | -9.04% |
| Total Other Revenue | -43.92% | -39.47% | -39.10% | -26.30% | 4.72% |
| Total Revenue | -37.53% | -40.08% | -39.43% | -26.76% | 1.65% |
| Cost of Revenue | -29.61% | -25.37% | -21.21% | -11.40% | -0.41% |
| Gross Profit | -59.95% | -78.06% | -82.43% | -62.28% | 7.97% |
| SG&A Expenses | 51.51% | 73.82% | 77.74% | 61.90% | 29.54% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 729.69% | -735.28% | -458.10% | 286.04% | -14.04% |
| Total Operating Expenses | -3.24% | -9.21% | -6.02% | 3.94% | 4.16% |
| Operating Income | -13,981.55% | -534.25% | -317.00% | -262.75% | -111.47% |
| Income Before Tax | 79.96% | 28.45% | -44.40% | -2,981.81% | -484.62% |
| Income Tax Expenses | -32.13% | 5.24% | 9.00% | 9.30% | 25.77% |
| Earnings from Continuing Operations | 79.93% | 28.43% | -44.37% | -2,915.91% | -483.35% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 79.93% | 28.43% | -44.37% | -2,915.91% | -483.35% |
| EBIT | -13,981.55% | -534.25% | -317.00% | -262.75% | -111.47% |
| EBITDA | -195.92% | -140.68% | -123.25% | -100.69% | 4.71% |
| EPS Basic | 84.65% | 52.99% | 24.20% | -2,622.51% | -800.51% |
| Normalized Basic EPS | 90.15% | 60.80% | 20.07% | -2,500.38% | -3,243.20% |
| EPS Diluted | 81.83% | 54.14% | 26.61% | -5,445.83% | -812.33% |
| Normalized Diluted EPS | 86.28% | 61.32% | 21.50% | -3,940.61% | -3,284.00% |
| Average Basic Shares Outstanding | 26.11% | 15.72% | 4.66% | -20.52% | -33.62% |
| Average Diluted Shares Outstanding | 33.66% | 10.48% | 0.26% | -23.39% | -30.23% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |